home > Horizant
The U.S. Food and Drug Administration approved Horizant (gabapentin enacarbil) Extended-Release Tablets in April 2011.
For more information, please click here
Stock Information: XNPT (Common Stock) Exchange: NASDAQ Visit Investor Relations >
© 2011 Copyright XenoPort, Inc. All rights reserved.
Terms and Conditions | Privacy
